| Locally renewing resident synovial macrophages provide a protective barrier for the joint S Culemann, A Grüneboom, JÁ Nicolás-Ávila, D Weidner, KF Lämmle, ... Nature 572 (7771), 670-675, 2019 | 436 | 2019 |
| Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus A Mackensen, F Müller, D Mougiakakos, S Böltz, A Wilhelm, M Aigner, ... Nature medicine 28 (10), 2124-2132, 2022 | 388 | 2022 |
| Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease RH Haberman, R Herati, D Simon, M Samanovic, RB Blank, M Tuen, ... Annals of the rheumatic diseases 80 (10), 1339-1344, 2021 | 276 | 2021 |
| COVID-19 revisiting inflammatory pathways of arthritis G Schett, B Manger, D Simon, R Caporali Nature Reviews Rheumatology 16 (8), 465-470, 2020 | 218 | 2020 |
| SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases D Simon, K Tascilar, F Fagni, G Krönke, A Kleyer, C Meder, R Atreya, ... Annals of the rheumatic diseases 80 (10), 1312-1316, 2021 | 197 | 2021 |
| German mobile apps in rheumatology: review and analysis using the Mobile Application Rating Scale (MARS) J Knitza, K Tascilar, EM Messner, M Meyer, D Vossen, A Pulla, P Bosch, ... JMIR mHealth and uHealth 7 (8), e14991, 2019 | 150 | 2019 |
| Mobile health usage, preferences, barriers, and eHealth literacy in rheumatology: patient survey study J Knitza, D Simon, A Lambrecht, C Raab, K Tascilar, M Hagen, A Kleyer, ... JMIR mHealth and uHealth 8 (8), e19661, 2020 | 134 | 2020 |
| Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis F Faustini, D Simon, I Oliveira, A Kleyer, J Haschka, M Englbrecht, ... Annals of the rheumatic diseases 75 (12), 2068-2074, 2016 | 118 | 2016 |
| Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion D Simon, K Tascilar, G Krönke, A Kleyer, MM Zaiss, F Heppt, C Meder, ... Nature communications 11 (1), 3774, 2020 | 104 | 2020 |
| COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses F Fagni, D Simon, K Tascilar, V Schoenau, M Sticherling, MF Neurath, ... The Lancet Rheumatology 3 (10), e724-e736, 2021 | 97 | 2021 |
| Analysis of periarticular bone changes in patients with cutaneous psoriasis without associated psoriatic arthritis D Simon, F Faustini, A Kleyer, J Haschka, M Englbrecht, S Kraus, ... Annals of the rheumatic diseases 75 (4), 660-666, 2016 | 95 | 2016 |
| Cutting edge: homeostasis of innate lymphoid cells is imbalanced in psoriatic arthritis A Soare, S Weber, L Maul, S Rauber, AM Gheorghiu, M Luber, I Houssni, ... The Journal of Immunology 200 (4), 1249-1254, 2018 | 84 | 2018 |
| Quantitative and qualitative changes of bone in psoriasis and psoriatic arthritis patients R Kocijan, M Englbrecht, J Haschka, D Simon, A Kleyer, S Finzel, S Kraus, ... Journal of Bone and Mineral Research 30 (10), 1775-1783, 2015 | 81 | 2015 |
| Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation—data from the prospective IVEPSA study E Kampylafka, D Simon, I d’Oliveira, C Linz, V Lerchen, M Englbrecht, ... Arthritis research & therapy 21, 1-9, 2019 | 77 | 2019 |
| Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective … E Kampylafka, I d’Oliveira, C Linz, V Lerchen, F Stemmler, D Simon, ... Arthritis research & therapy 20, 1-10, 2018 | 66 | 2018 |
| High prevalence of tenosynovial inflammation before onset of rheumatoid arthritis and its link to progression to RA—A combined MRI/CT study A Kleyer, M Krieter, I Oliveira, F Faustini, D Simon, N Kaemmerer, ... Seminars in arthritis and rheumatism 46 (2), 143-150, 2016 | 58 | 2016 |
| A set of serum markers detecting systemic inflammation in psoriatic skin, entheseal, and joint disease in the absence of C-reactive protein and its link to clinical disease … MV Sokolova, D Simon, K Nas, MM Zaiss, Y Luo, Y Zhao, J Rech, ... Arthritis research & therapy 22, 1-8, 2020 | 52 | 2020 |
| Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease D Simon, K Tascilar, F Fagni, K Schmidt, G Krönke, A Kleyer, A Ramming, ... Annals of the Rheumatic Diseases 81 (7), 1023-1027, 2022 | 51 | 2022 |
| Accuracy, patient-perceived usability, and acceptance of two symptom checkers (Ada and Rheport) in rheumatology: interim results from a randomized controlled crossover trial J Knitza, J Mohn, C Bergmann, E Kampylafka, M Hagen, D Bohr, H Morf, ... Arthritis Research & Therapy 23, 1-7, 2021 | 50 | 2021 |
| Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection HM Schenker, M Hagen, D Simon, G Schett, B Manger Rheumatology 60 (1), 479-480, 2021 | 49 | 2021 |
